ISRCTN63987586已完成未知
A Phase II randomised controlled trial of an early tailored cognitive behavioural therapy based intervention for depression in those newly diagnosed with multiple sclerosis
Multiple Sclerosis Research Australia0 个研究点目标入组 60 人开始时间: 2017年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/31959224 protocol (added 22/01/2020)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Mild to moderately depressed patients with MS
- •2. Diagnosed with MS within the last 5 years and are considered newly diagnosed.
- •3. Adult (i.e., 18-65 years old)
排除标准
- •1. Gross cognitive impairment that would make participation in the 8 one hour sessions of Cognitive Behavioural Therapy distressing
- •2. Unable to speak or read English
- •3. Acute organic brain syndrome (e.g., delirium)
- •4. Serious psychological disorder (e.g., psychosis)
- •5. Assessed with the BDI-II and the SCID-5 as being severely depressed
- •6. Already undertaking psychological treatment for depression/anxiety
- •7. Taking antidepressants for less than two months
研究者
相似试验
进行中（未招募）
2 期
Radiotherapy combined with immunotherapy in metastatic non-small cell lung cancer patientsAdvanced non-small cell lung cancer, stage IVMalignant neoplasm the lung, non-small cell lung cancerCancerISRCTN49817477Maastricht University88
已完成
不适用
Evaluation of Groups for Alcohol-misusing Short-term PrisonersMental and behavioural disorders due to use of alcoholISRCTN68904585Abertawe Bro Morgannwg University Health Board (UK)238
已完成
2 期
Trial of ursodeoxycholic acid for Parkinson’s diseaseParkinson's diseaseISRCTN73371260Sheffield Teaching Hospitals NHS Foundation Trust30
终止
2 期
apatinib plus capecitabine versus continued trastuzumab plus capecitabine after local therapy in patients with ErbB2-positive metastatic breast cancer developing brain metastasis/esBreast cancer, developing brain metastasis/esBreast cancerCancerISRCTN58771616eeds Teaching Hospitals NHS Trust (UK)30
已完成
不适用
Evaluation of a computer aid for assessing stomach symptomsCancerISRCTN12595588niversity of Durham (UK)530